Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI)-Clinigen Group plc Amend

15th Dec 2021 16:27

RNS Number : 7927V
JPMorgan Securities Plc
15 December 2021
 

 

AMENDMENT

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Clinigen Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

financial adviser to Triton Investment Management

(d) Date dealing undertaken:

9 December 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

0.1p ordinary

Purchase

 

Sale

620,978

 

167,870

9.3550 GBP

 

9.3400 GBP

9.0558 GBP

 

9.0691 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.1p ordinary

Equity Swap

Decrease Long

 

 

 

 

 

 

 

 

 

 

 

Decrease Short

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Long

 

 

 

 

Increase Short

 

 

 

 

 

 

 

 

 

 

 

 

Opening a long position

 

Opening a short position

 

34

 4,533

 9,160

 22,118

 1,105

 15,067

 17,087

 23,595

 8,185

 2,945

 8,959

 

 790

 1,620

 100

 5,000

 5,000

 2,927

 1,952

 7,357

 3,176

 1,444

 3,632

 6,400

 17

 230

 8,889

 20,000

 2,071

 1,410

 10,518

 1,132

 7,698

 9,464

 63

 

 4,270

 2,053

 162

 13,622

 

 81

 99

 4,726

 6,519

 240

 5,217

 5,540

 90,620

 20,358

 5,217

 12,295

 77,561

 

 10,000

 

 2,932

 89,900

9.0707 GBP

9.1373 GBP

9.1764 GBP

9.1771 GBP

9.2225 GBP

9.2314 GBP

9.2376 GBP

9.2592 GBP

9.2652 GBP

9.2994 GBP

9.3000 GBP

9.1472 GBP

9.1479 GBP

9.1550 GBP

9.1585 GBP

9.1588 GBP

9.1598 GBP

9.2006 GBP

9.2023 GBP

9.2122 GBP

9.2345 GBP

9.2354 GBP

9.2399 GBP

9.2400 GBP

9.2510 GBP

9.2576 GBP

9.2677 GBP

9.2687 GBP

9.2707 GBP

9.2778 GBP

9.2790 GBP

9.2972 GBP

9.2995 GBP

9.3000 GBP

9.1296 GBP

9.2748 GBP

9.2763 GBP

9.3000 GBP

9.0701 GBP

9.1251 GBP

9.1792 GBP

9.1886 GBP

9.2608 GBP

9.2846 GBP

9.2872 GBP

9.3000 GBP

9.3019 GBP

9.3047 GBP

9.3052 GBP

9.2655 GBP

9.3398 GBP

9.2452 GBP

9.3370 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

15 December 2021

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGPGAPPUPGGQA

Related Shares:

CLIN.L
FTSE 100 Latest
Value8,415.25
Change0.00